These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37715899)

  • 1. Steroid refractory severe ulcerative colitis after kidney transplantation successfully treated with infliximab.
    Kojima K; Takada J; Kamei M; Kubota M; Ibuka T; Shimizu M
    Clin J Gastroenterol; 2023 Dec; 16(6):848-853. PubMed ID: 37715899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo ulcerative colitis after kidney transplantation treated with infliximab.
    Oki R; Hidaka S; Sasaki A; Teshima S; Mochida Y; Miyake K; Ishioka K; Moriya H; Ohtake T; Kobayashi S
    CEN Case Rep; 2021 Nov; 10(4):500-505. PubMed ID: 33829404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological healing after infliximab induction therapy in children with ulcerative colitis.
    Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
    World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of infliximab and tacrolimus combination therapy in a patient with ulcerative colitis refractory to infliximab dose intensification plus azathioprine.
    Cortes X; Borrás-Blasco J; Fernendez S; Moreno M; Rodríguez J; Molés JR; Casterá E
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):125-8. PubMed ID: 26754306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis.
    Zhao HN; Jiang M; Sun MJ; Dai C
    Saudi J Gastroenterol; 2021; 27(4):191-200. PubMed ID: 34380865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis.
    Olsen T; Rismo R; Gundersen MD; Paulssen EJ; Johnsen K; Kvamme JM; Goll R; Florholmen J
    Cytokine; 2016 Mar; 79():90-5. PubMed ID: 26775117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study.
    Nasuno M; Miyakawa M; Tanaka H; Motoya S
    Digestion; 2017; 95(1):67-71. PubMed ID: 28052276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of a simple ulcer associated with ulcerative colitis that demonstrated a good clinical response to infliximab].
    Kishi M; Sou S; Ishihara H; Terabe H; Yasaka M; Kuhara K; Takeda T; Shimokoube M; Morimitsu Y; Miyazono K
    Nihon Shokakibyo Gakkai Zasshi; 2015; 112(9):1682-8. PubMed ID: 26346358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.
    Narula N; Marshall JK; Colombel JF; Leontiadis GI; Williams JG; Muqtadir Z; Reinisch W
    Am J Gastroenterol; 2016 Apr; 111(4):477-91. PubMed ID: 26856754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of short-term therapeutic efficacy between infliximab and tacrolimus for moderate to severe ulcerative colitis.
    Yamagami H; Nishida Y; Nagami Y; Hosomi S; Yukawa T; Otani K; Tanaka F; Taira K; Kamata N; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y
    Rom J Intern Med; 2017 Sep; 55(3):151-157. PubMed ID: 28222041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo ulcerative colitis and autoimmune hepatitis after living related liver transplantation from cytomegalovirus-positive donor to cytomegalovirus-negative recipient: a case report.
    Sakamoto T; Sato Y; Yamamoto S; Oya H; Hatakeyama K
    Transplant Proc; 2012 Mar; 44(2):570-3. PubMed ID: 22410071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of early response to infliximab in patients with ulcerative colitis.
    Ferrante M; Vermeire S; Katsanos KH; Noman M; Van Assche G; Schnitzler F; Arijs I; De Hertogh G; Hoffman I; Geboes JK; Rutgeerts P
    Inflamm Bowel Dis; 2007 Feb; 13(2):123-8. PubMed ID: 17206703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inpatient infliximab is ineffective at preventing colectomy for steroid refractory extensive colitis.
    Andrew RE; Lauria A; Puleo FJ; Berg A; Stewart DB
    J Surg Res; 2017 Nov; 219():18-24. PubMed ID: 29078879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis.
    Liu YJ; Fan H; Zhen WW; Yu X; Chen JT; Wang CD
    Medicine (Baltimore); 2018 Aug; 97(32):e11440. PubMed ID: 30095612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
    Nelson R; Liao C; Fichera A; Rubin DT; Pekow J
    Inflamm Bowel Dis; 2014 Jan; 20(1):14-20. PubMed ID: 24297054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
    Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Nardone OM; De Vitis I; Papa A; Rapaccini GL; Guidi L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1368-74. PubMed ID: 24983979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
    Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
    Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcerative colitis endoscopic index of severity is associated with long-term prognosis in ulcerative colitis patients treated with infliximab.
    Saigusa K; Matsuoka K; Sugimoto S; Arai M; Kiyohara H; Takeshita K; Mizuno S; Mori K; Nanki K; Takeshita T; Nakazato Y; Yajima T; Naganuma M; Hisamatsu T; Ogata H; Iwao Y; Kanai T
    Dig Endosc; 2016 Sep; 28(6):665-70. PubMed ID: 26997640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-Onset of Acute Severe Ulcerative Colitis: Clinical Case.
    Dorofeyev AE; Rassokhina OA; Dorofeyeva AA
    Dig Dis; 2017; 35(1-2):45-49. PubMed ID: 28147350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.